US FDA To Advisory Committee Industry Reps: Don’t Talk Too Much

No sound
FDA believes advisory committee industry reps should be seen but not heard. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US Advisory Committees

More from United States